Regulus Therapeutics Newsroom

JonesTrading Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 29 12:32 ET

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 12 08:31 ET

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 11 07:31 ET

Regulus Therapeutics Poised for Growth: Promising ADPKD Study Results and Strategic Milestones Drive Buy Rating

TipRanksNov 11 06:40 ET

Buy Rating for Regulus Therapeutics Driven by Promising Clinical and Regulatory Prospects for RGLS8429

TipRanksNov 11 01:31 ET

Regulus Therapeutics Analyst Ratings

BenzingaOct 30 08:23 ET

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 30 07:31 ET

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 8 10:31 ET

Regulus Therapeutics Analyst Ratings

BenzingaAug 14 13:37 ET

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 14 08:31 ET

Regulus Therapeutics Analyst Ratings

BenzingaAug 9 17:27 ET

Buy Rating Reaffirmed for Regulus Therapeutics Amidst Promising Clinical Data and Progress Towards Pivotal Trial

TipRanksAug 9 08:15 ET

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 2 08:36 ET

Oppenheimer Initiates Regulus Therapeutics at Outperform With $7 Price Target

MT NewswiresAug 2 07:39 ET

Oppenheimer Initiates Regulus Therapeutics(RGLS.US) With Buy Rating, Announces Target Price $7

Moomoo NewsAug 1 17:32 ET

Regulus Therapeutics Analyst Ratings

BenzingaJul 16 08:14 ET

Buy Rating Affirmed for Regulus Therapeutics Amid Positive RGLS8429 Study Results

TipRanksJul 16 06:27 ET

Regulus Therapeutics Analyst Ratings

BenzingaJun 25 06:48 ET

Regulus Therapeutics Analyst Ratings

BenzingaMay 31 09:01 ET

Regulus Therapeutics Analyst Ratings

BenzingaMay 10 07:50 ET